Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Objective radiologic assessment of body composition in patients with end-stage liver disease: going beyond the BMI.

Cruz RJ Jr, Dew MA, Myaskovsky L, Goodpaster B, Fox K, Fontes P, DiMartini A.

Transplantation. 2013 Feb 27;95(4):617-22. doi: 10.1097/TP.0b013e31827a0f27.

2.

Impact of Skeletal Muscle Mass Index, Intramuscular Adipose Tissue Content, and Visceral to Subcutaneous Adipose Tissue Area Ratio on Early Mortality of Living Donor Liver Transplantation.

Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yagi S, Kamo N, Okajima H, Uemoto S.

Transplantation. 2017 Mar;101(3):565-574. doi: 10.1097/TP.0000000000001587.

PMID:
27926595
3.

Abdominal adiposity, body composition and survival after liver transplantation.

Terjimanian MN, Harbaugh CM, Hussain A, Olugbade KO Jr, Waits SA, Wang SC, Sonnenday CJ, Englesbe MJ.

Clin Transplant. 2016 Mar;30(3):289-94. doi: 10.1111/ctr.12688. Epub 2016 Feb 13.

4.

Quantitative measures of visceral adiposity and body mass index in predicting rectal cancer outcomes after neoadjuvant chemoradiation.

Clark W, Siegel EM, Chen YA, Zhao X, Parsons CM, Hernandez JM, Weber J, Thareja S, Choi J, Shibata D.

J Am Coll Surg. 2013 Jun;216(6):1070-81. doi: 10.1016/j.jamcollsurg.2013.01.007. Epub 2013 Mar 21.

5.

Relation of regional fat distribution to left ventricular structure and function.

Neeland IJ, Gupta S, Ayers CR, Turer AT, Rame JE, Das SR, Berry JD, Khera A, McGuire DK, Vega GL, Grundy SM, de Lemos JA, Drazner MH.

Circ Cardiovasc Imaging. 2013 Sep;6(5):800-7. doi: 10.1161/CIRCIMAGING.113.000532. Epub 2013 Aug 8.

6.

Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program.

Bray GA, Jablonski KA, Fujimoto WY, Barrett-Connor E, Haffner S, Hanson RL, Hill JO, Hubbard V, Kriska A, Stamm E, Pi-Sunyer FX; Diabetes Prevention Program Research Group.

Am J Clin Nutr. 2008 May;87(5):1212-8.

7.

 Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD).

Choudhary NS, Duseja A, Kalra N, Das A, Dhiman RK, Chawla YK.

Ann Hepatol. 2012 Jul-Aug;11(4):478-86.

8.

Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.

Fujiwara N, Nakagawa H, Kudo Y, Tateishi R, Taguri M, Watadani T, Nakagomi R, Kondo M, Nakatsuka T, Minami T, Sato M, Uchino K, Enooku K, Kondo Y, Asaoka Y, Tanaka Y, Ohtomo K, Shiina S, Koike K.

J Hepatol. 2015 Jul;63(1):131-40. doi: 10.1016/j.jhep.2015.02.031. Epub 2015 Feb 24.

9.

Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study.

Shah RV, Murthy VL, Abbasi SA, Blankstein R, Kwong RY, Goldfine AB, Jerosch-Herold M, Lima JA, Ding J, Allison MA.

JACC Cardiovasc Imaging. 2014 Dec;7(12):1221-35. doi: 10.1016/j.jcmg.2014.07.017. Epub 2014 Nov 5.

10.

Relationship of visceral and subcutaneous adiposity with renal function in people with type 2 diabetes mellitus.

Kim SR, Yoo JH, Song HC, Lee SS, Yoo SJ, Kim YD, Lim YS, Kim HW, Yang CW, Kim YS, Choi EJ, Kim YK.

Nephrol Dial Transplant. 2011 Nov;26(11):3550-5. doi: 10.1093/ndt/gfq634. Epub 2010 Oct 28.

PMID:
21030458
11.

Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer.

Slaughter KN, Thai T, Penaroza S, Benbrook DM, Thavathiru E, Ding K, Nelson T, McMeekin DS, Moore KN.

Gynecol Oncol. 2014 Apr;133(1):11-5. doi: 10.1016/j.ygyno.2014.01.031.

PMID:
24680585
12.

Visceral obesity and the risk of Barrett's esophagus in Japanese patients with non-alcoholic fatty liver disease.

Akiyama T, Yoneda M, Inamori M, Iida H, Endo H, Hosono K, Yoneda K, Fujita K, Koide T, Tokoro C, Takahashi H, Goto A, Abe Y, Kirikoshi H, Kobayashi N, Kubota K, Saito S, Nakajima A.

BMC Gastroenterol. 2009 Jul 21;9:56. doi: 10.1186/1471-230X-9-56.

13.

Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study).

Hiuge-Shimizu A, Kishida K, Funahashi T, Ishizaka Y, Oka R, Okada M, Suzuki S, Takaya N, Nakagawa T, Fukui T, Fukuda H, Watanabe N, Yoshizumi T, Nakamura T, Matsuzawa Y, Yamakado M, Shimomura I.

Ann Med. 2012 Feb;44(1):82-92. doi: 10.3109/07853890.2010.526138. Epub 2010 Oct 22.

PMID:
20964583
14.

Visceral adiposity is negatively associated with bone density and muscle attenuation.

Zhang P, Peterson M, Su GL, Wang SC.

Am J Clin Nutr. 2015 Feb;101(2):337-43. doi: 10.3945/ajcn.113.081778. Epub 2014 Nov 26.

15.

Volumetric fat ratio and not body mass index is predictive of ileocolectomy outcomes in Crohn's disease patients.

Connelly TM, Juza RM, Sangster W, Sehgal R, Tappouni RF, Messaris E.

Dig Surg. 2014;31(3):219-24. doi: 10.1159/000365359. Epub 2014 Sep 24.

PMID:
25277149
16.

Gender differences in the association of visceral and subcutaneous adiposity with adiponectin in African Americans: the Jackson Heart Study.

Bidulescu A, Liu J, Hickson DA, Hairston KG, Fox ER, Arnett DK, Sumner AE, Taylor HA, Gibbons GH.

BMC Cardiovasc Disord. 2013 Feb 22;13:9. doi: 10.1186/1471-2261-13-9.

17.

Utilizing quantitative measures of visceral adiposity in evaluating trauma patient outcomes.

Docimo S Jr, Lamparello B, Cohen MF, Kopatsis A, Vinces F.

Int J Surg. 2015 Sep;21:51-6. doi: 10.1016/j.ijsu.2015.06.069. Epub 2015 Jul 9.

PMID:
26166742
18.

Retinol-binding protein 4 expression in visceral and subcutaneous fat in human obesity.

Bajzová M, Kováciková M, Vítková M, Klimcáková E, Polák J, Kovácová Z, Viguerie N, Vedral T, Mikulásek L, Srámková P, Srp A, Hejnová J, Langin D, Stich V.

Physiol Res. 2008;57(6):927-34. Epub 2007 Nov 30.

19.

Impact of visceral fat on gene expression profile in peripheral blood cells in obese Japanese subjects.

Obata Y, Maeda N, Yamada Y, Yamamoto K, Nakamura S, Yamaoka M, Tanaka Y, Masuda S, Nagao H, Fukuda S, Fujishima Y, Kita S, Nishizawa H, Funahashi T, Matsubara KI, Matsuzawa Y, Shimomura I.

Cardiovasc Diabetol. 2016 Nov 29;15(1):159.

Supplemental Content

Support Center